<?xml version="1.0" encoding="UTF-8"?><feed xmlns="http://www.w3.org/2005/Atom">
  <title>临床研究观潮 | wechat-feeds</title>
  <id>https://github.com/hellodword/wechat-feeds</id>
  <updated>2020-11-01T11:19:08+08:00</updated>
  <subtitle>介绍大药厂临床试验、国内创新药动态、FDA\EMA\PMDA等法规指南、药物评审报告、行业潜力分析，组织焦点讨论或会议，深度挖掘临床试验数据本质意义；服务于试验机构、PM、CRO以及CRA\CRC。</subtitle>
  <link href="https://github.com/hellodword/wechat-feeds"></link>
  <author>
    <name>hellodword</name>
  </author>
  <entry>
    <title>重磅FDA 最新BA/BE留样数量解释-30支即可</title>
    <updated>2020-08-25T15:24:17+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-08-25:/s/RHlP82V-f5TIVq89xMobrA</id>
    <link href="https://mp.weixin.qq.com/s/RHlP82V-f5TIVq89xMobrA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>当齐鲁的“伟哥”贵过你手中的那瓶“农夫山泉时”</title>
    <updated>2020-08-20T18:41:14+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-08-20:/s/qNL2etVHbxwXpdK0sgdsUg</id>
    <link href="https://mp.weixin.qq.com/s/qNL2etVHbxwXpdK0sgdsUg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>肿瘤学中双特异性抗体早期临床开发的定量药理学策略</title>
    <updated>2020-08-19T13:04:26+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-08-19:/s/53qGo5uIJm1gVTpAuTRTZA</id>
    <link href="https://mp.weixin.qq.com/s/53qGo5uIJm1gVTpAuTRTZA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>新冠疫苗指导原则</title>
    <updated>2020-08-16T20:39:42+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-08-16:/s/HXWMzVQGxA6hhlFwuQiOXA</id>
    <link href="https://mp.weixin.qq.com/s/HXWMzVQGxA6hhlFwuQiOXA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>从另外一个角度去看——证券分析师的报告</title>
    <updated>2020-08-15T21:46:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-08-15:/s/HlQFrtm70_btiD3s7XDYEg</id>
    <link href="https://mp.weixin.qq.com/s/HlQFrtm70_btiD3s7XDYEg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>靶标介导的药物处置（TMDD）模型教程</title>
    <updated>2020-08-12T14:31:44+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-08-12:/s/7TKq7S1H34bvkqBJ2_4_CA</id>
    <link href="https://mp.weixin.qq.com/s/7TKq7S1H34bvkqBJ2_4_CA" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>有情怀的开发者-MaS Studio-Nonmen</title>
    <updated>2020-08-10T13:16:55+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-08-10:/s/bMb2J_bzxihpvyb0v_j8Bg</id>
    <link href="https://mp.weixin.qq.com/s/bMb2J_bzxihpvyb0v_j8Bg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>PK软件知多少？</title>
    <updated>2020-08-05T21:11:01+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-08-05:/s/jY0Erl53wJRuYMFXucciTg</id>
    <link href="https://mp.weixin.qq.com/s/jY0Erl53wJRuYMFXucciTg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA-临床药理学可以做什么（10）日本FIH起始剂量考虑</title>
    <updated>2020-07-21T21:08:47+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-07-21:/s/jmrgGDfaFiBNukgkw05jPg</id>
    <link href="https://mp.weixin.qq.com/s/jmrgGDfaFiBNukgkw05jPg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
  <entry>
    <title>FDA-临床药理学可以做什么（8）非临床到临床</title>
    <updated>2020-07-21T20:03:08+08:00</updated>
    <id>tag:mp.weixin.qq.com,2020-07-21:/s/ehBb9-hXat-Jtc40_-FWhg</id>
    <link href="https://mp.weixin.qq.com/s/ehBb9-hXat-Jtc40_-FWhg" rel="alternate"></link>
    <summary type="html"></summary>
  </entry>
</feed>